文献速递精神分裂症与精神病性障碍

精神分裂症患者皮层谷氨酸与工作记忆激活的关联:质子磁共振波谱与功能磁共振成像多模态研究

Association of Cortical Glutamate and Working Memory Activation in Patients With Schizophrenia: A Multimodal Proton Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study.
PubMed 文献 · Biol Psychiatry · 2019-07-26

该研究纳入90名受试者(35名对照、36名服药患者、19名未服药患者),采用磁共振波谱测定左侧背外侧前额叶皮层谷氨酸浓度,并在n-back工作记忆任务期间用功能磁共振成像测量局部激活。服药与未服药患者工作记忆表现均受损,服药患者左侧DLPFC激活显著降低、未服药患者呈边缘性降低,但组间谷氨酸浓度无差异;谷氨酸浓度与工作记忆激活的关联受服药状态影响,未服药患者呈正相关而服药患者无此关联。

要点

  • 服药与未服药精神分裂症患者工作记忆表现均受损。
  • 服药患者左侧DLPFC工作记忆激活显著低于对照,未服药患者呈边缘性降低。
  • 未服药患者左侧DLPFC谷氨酸浓度与工作记忆激活正相关,服药患者无此关联。

核心结论

  • 精神分裂症患者工作记忆依赖的左侧DLPFC激活与局部谷氨酸浓度相关,且该关联受抗精神病药治疗状态影响。

研究设计与样本

  • 研究纳入90名受试者,包括35名对照、36名服药患者和19名未服药患者,采集磁共振波谱数据。
  • 在左侧DLPFC估算谷氨酸浓度,受试者在功能磁共振成像期间执行n-back工作记忆任务(2-back对比0-back),测量左侧DLPFC局部激活。
  • 采用线性回归模型分析谷氨酸浓度与工作记忆激活的关联,并纳入与组别的交互效应以分析服药状态的影响。

主要发现

  • 服药与未服药精神分裂症患者均表现出工作记忆表现受损。
  • 与对照相比,服药患者左侧DLPFC工作记忆激活显著降低,未服药患者呈边缘性降低。
  • 各组间局部谷氨酸浓度无差异。
  • 服药状态对左侧DLPFC局部谷氨酸浓度与工作记忆激活的关联有不同影响:未服药患者呈正相关,服药患者无此关联。

临床怎么用

  • 在解读精神分裂症患者DLPFC谷氨酸与工作记忆激活关系时,需考虑抗精神病药治疗状态的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive deficits such as working memory (WM) impairment are core features of schizophrenia. One candidate marker for the integrity of synaptic neurotransmission necessary for cognitive processes is glutamate. It is frequently postulated that antipsychotic medication possibly alters functional mechanisms in the living brain. We tested in vivo for group differences in activation of the dorsolateral prefrontal cortex (DLPFC) during WM performance and the association with glutamate concentration in DLPFC depending on medication status. METHODS: A total of 90 subjects (35 control subjects, 36 medicated patients, and 19 unmedicated patients) contributed magnetic resonance spectroscopy data. We estimated glutamate in left DLPFC. Subjects performed an n-back WM task (2-back vs. 0-back) during functional magnetic resonance imaging, and local activation in left DLPFC was measured. For analysis of association with medication status, we calculated linear regression models including an interaction effect with group. RESULTS: Medicated and unmedicated patients with schizophrenia showed impaired performance. We found significantly reduced WM activation in left DLPFC in medicated patients and a trendwise reduction in unmedicated patients as compared with control subjects. We found no group difference in local glutamate concentration. However, we found differential effects of medication status on the association between local glutamate concentration and WM activation in left DLPFC, with a positive association in unmedicated patients but not in medicated patients. CONCLUSIONS: We provide evidence that WM-dependent activation is associated with glutamate concentration in unmedicated patients with schizophrenia. Our finding points to putative allostatic changes that affect the functioning of the brain and might be altered through medication.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kaminski J, Gleich T, Fukuda Y, et al. Association of Cortical Glutamate and Working Memory Activation in Patients With Schizophrenia: A Multimodal Proton Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study. Biol Psychiatry. 2019. PMID: 31521336. doi:10.1016/j.biopsych.2019.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。